CClinicalTrials.gg
Active, not recruitingNCT06255171Updated Dec 19, 2024

Social Media and Suicidal Behaviour - Study 1

An interventional study of Reading journalistic posts and articles on social media on nature and Reading journalistic posts and articles on social media on deaths by suicide in Suicidal Behaviour, sponsored by University of Primorska. Active, not recruiting at 1 site in Slovenia. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-19.

Sponsored by University of Primorska · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
All
01

Study summary

There is limited research investigating the correlation between suicidal behavior in the general population and online journalism reporting on suicide. Even less explored are the roles and characteristics of suicide-related news posts on social media platforms, along with reader comments, and their association with users' experiences. The primary objective of this randomized controlled trial is to experimentally examine the influence of these post features on user perceptions. Participants are expected to be university students or young adults.

In line with this aim, the following research question has been posed:

How do users of social media and forums perceive news posts about suicide on social media platforms?

Participants will complete a screening battery of questionnaires. Those who will be eligible to participate will be divided into 1 experimental and 2 control groups. Firstly the participants will fill out a questionnaire regarding their current mood. Each group will read posts of a different theme, one of them will be suicidal behavior, deaths due to traffic accidents, and nature. They will be asked to observe and read 4 social media posts and their corresponding articles. After each article, they will answer a few questions on how they perceived these articles and how are they currently feeling. After the main part of the study, all groups of participants will be involved in a group debriefing conversation.

Read the detailed description

The clinical trial will comprise three samples:

  • The experimental group sample (experimental condition: reading articles on death by suicide). Experimental group sample will include 20-25 adult residents of Slovenia.
  • The first control group sample (control condition: reading articles on deaths due to traffic accidents). First control group sample will include 20-25 adult residents of Slovenia.
  • The second control group sample (control condition: reading neutral articles about nature). Second control group sample will include 20-25 adult residents of Slovenia.

The total number of participants in all three groups will range from 60 to 80 individuals, they will be recruited through various channels. The research group will disseminate the link to the online invitation using the 1KA platform, along with a request for its dissemination to the departments of the University of Primorska and other public universities in Slovenia. Members of the research team will also share the research invitation with their students. Recruitment will be extended through media announcements, our website zivziv.si, and our Facebook account, UP Insititute Andrej Marušič. Additional invitations to participate in the study may be extended through brief presentations in courses across different academic disciplines, in collaboration with the respective course instructors.

The research invitation will be freely accessible online and will include information about the compensation for participation. The invitation will also include a consent form, which participants will provide at the first stage and which will cover all further stages of study participation. The online consent form will be presented on the 1KA platform.

The sample will exclusively include adult residents of Slovenia. Participants who receive the invitation and decide to participate will:

i) Read detailed instructions about the project and participation and complete an informed consent: Clicking on the link will take potential participants to the first step of research participation on the 1KA platform. They will read all the relevant information about the purpose, implementation, and then proceed to complete an informed consent indicating their conscious decision to participate. If participants provide all necessary information and the informed consent for participation, they will receive a link to the next step on the 1KA platform-completing a battery of questionnaires for screening purposes (detailed in the section on the description of methods).

ii) Complete the screening battery of questionnaires: Participants will then receive a link to a battery of questionnaires assessing subjective well-being, the presence of depression symptoms, and/or suicidal thoughts. After completing the questionnaire battery on the 1KA platform, all participants will receive an invitation to participate in the experimental laboratory study or a notice of potential rejection via their provided email address. The rejection notice will include an explanation of the rejection, sources of assistance in distress, the significance of seeking help, and our contact information. This notice will be sent to those participants who exhibit diminished subjective well-being, the presence of depression symptoms, and/or suicidal thoughts for their safety and well-being, excluding them from the study.

Participants who do not exceed the predefined threshold values will be invited to participate in the main part of the study.

iii) Participate in the main part of the study (experimental and control groups): The main part of the study will include the experimental group and two control groups of participants. Participants will be randomly assigned to groups, ensuring that the experimental and control groups are comparable in terms of the number of participants, gender, age, and their field of study or achieved education level (social sciences or natural sciences). Other characteristics of participants cannot be predicted at this stage.

Participants will receive instructions for participating in the study. Potential participants will be informed that the remainder of the study will involve in-person participation under various experimental conditions (exposure to one of three different content modules). Each participant will be exposed to only one condition and its corresponding content module, but they will not know which one before or during active participation in the study. Participants will be informed in advance that they will not know which condition they are randomly assigned to during the exposure. This approach aims to ensure transparency while achieving valid findings. Participants will be informed of their assigned condition immediately after completing their participation in the main part of the study. After the main part of the study, all groups of participants will be involved in a group debriefing conversation, providing an opportunity for feedback from both the study's facilitators and participants. It will facilitate clarification of conditions (experimental or control group) and provide a platform for discussing participants' feelings, potential dilemmas, questions, etc.

02

Conditions studied

  • Suicidal Behaviour

Browse trials for

Keywords

  • social media
  • suicide
  • reporting on suicide
  • university students
  • impact of reporting
  • suicidal behaviour
03

In context

Suicide

701 studies on the registry are indexed under Suicide; 183 are open to participants now.

This study's enrollment of 62 is below the median of 104 across 560 interventional studies indexed under Suicide.

Browse Suicide studies →

Lead sponsor

University of Primorska is the lead sponsor of 53 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • over the age of 18
  • providing an informed consent for participation in the study
  • not exceeding the limit values on any of the questionnaires of the screening battery

Exclusion criteria

Exclusion Criteria:

  • under the age of 18
  • not providing an informed consent for participation in the study
  • exceeding the limit values on at least one questionnaire of the screening battery
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
62 participants (actual)

Study arms

  • Other
    Nature articles - control 1

    Participants will read posts and articles about nature.

    Behavioral: Reading journalistic posts and articles on social media on nature

  • Experimental
    Death by suicide articles

    Participants will read posts and articles about death by suicide.

    Behavioral: Reading journalistic posts and articles on social media on deaths by suicide

  • Other
    Articles about traffic-related deaths - control 2

    Participants will read posts and articles about traffic-related deaths.

    Behavioral: Reading journalistic posts and articles on social media on traffic-related deaths

Interventions

  • BehavioralReading journalistic posts and articles on social media on nature

    Reading journalistic posts and articles, published on social media, regarding nature.

  • BehavioralReading journalistic posts and articles on social media on deaths by suicide

    Reading journalistic posts and articles, published on social media, regarding deaths by suicide.

  • BehavioralReading journalistic posts and articles on social media on traffic-related deaths

    Reading journalistic posts and articles, published on social media, regarding traffic-related deaths

06

What researchers measure

Primary outcomes

  1. The experience of a social media user when reading posts

    For the purposes of this study, questions were formulated about the experience of publication

    Time frame: Approximately 1 minute after being presented each social media post

Secondary outcomes

  1. Self-rating of mood - Pleasant-Unpleasant Scale

    Using the Brief Mood Introspection Scale; BMIS; Mayer in Gaschke, 1988. Pleasant-Unpleasant Scale, min = 16, max = 64, a higher score indicating a more pleasant mood

    Time frame: Before and approximately 1 minute after being presented each social media post

  2. Self-rating of mood - Arousal-Calm Mood Scale

    Using the Brief Mood Introspection Scale; BMIS; Mayer in Gaschke, 1988. Arousal-Calm Scale, min = 12, max = 48, a higher score indicating a more aroused mood

    Time frame: Before and approximately 1 minute after being presented each social media post

07

Study locations

1 site
  • University of Primorska
    Koper, 6000, Slovenia
08

References and documents

Study documents

  • Informed consent form · Feb 2, 2024

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 19, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06255171
Lead sponsor
University of Primorska
Collaborators
Slovenian Research Agency
Responsible party
Sponsor
First posted
Feb 13, 2024
Start date
Dec 1, 2023
Primary completion
Aug 12, 2024
Completion
Oct 2025 (estimated)
Last update
Dec 19, 2024

Study contacts

Diego De Leo
study director · University of Primorska
Vita Poštuvan
principal investigator · University of Primorska

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion